Nitin Ohri, MD, MS, explains the rationale for combining thoracic radiotherapy with dual PD-1 and LAG-3 blockade in locally advanced NSCLC. At the 2026 ASTRO Annual Meeting, Marcio A. Fagundes, MD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results